Metaraminol bitartrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for metaraminol bitartrate and what is the scope of patent protection?
Metaraminol bitartrate
is the generic ingredient in two branded drugs marketed by Merck, Abraxis Pharm, Elkins Sinn, Fresenius Kabi Usa, Gd Searle Llc, and Slayback Pharma Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Summary for metaraminol bitartrate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 627 |
DailyMed Link: | metaraminol bitartrate at DailyMed |
Medical Subject Heading (MeSH) Categories for metaraminol bitartrate
US Patents and Regulatory Information for metaraminol bitartrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | ARAMINE | metaraminol bitartrate | INJECTABLE;INJECTION | 009509-002 | Dec 22, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slayback Pharma Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 211304-001 | Aug 24, 2021 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Gd Searle Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 086418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abraxis Pharm | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080431-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080722-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |